Biogaia AB ADR (BIOGY)
Company Info
Highlights
$1.08B
$0.32
29.02
$1.42B
$1.03B
$485.72M
$8.98 - $11.97
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Biogaia AB ADR (BIOGY) returned -9.83% year-to-date (YTD) and -23.38% over the past 12 months.
BIOGY
-9.83%
-16.90%
-6.30%
-23.38%
-0.34%
-0.12%
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of BIOGY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 17.88% | -1.30% | -6.73% | -16.90% | -9.83% | ||||||||
| 2024 | 1.97% | 18.57% | -10.80% | 14.63% | -0.37% | 2.51% | -2.83% | -3.08% | -14.99% | 3.91% | 5.05% | ||
| 2023 | 4.95% | 11.89% | -7.85% | 9.63% | 1.04% | 0.55% | -5.05% | -4.60% | 1.64% | 12.31% | -0.92% | 23.50% | |
| 2022 | -13.79% | 14.09% | 10.71% | -18.59% | -0.81% | -26.33% | -1.33% | 12.95% | 3.89% | -25.00% | |||
| 2021 | -0.55% | -18.24% | -6.48% | 5.65% | 10.66% | 2.02% | 1.00% | -5.07% | -0.79% | 6.49% | -8.15% | ||
| 2020 | -37.48% | 40.95% | 11.89% | 7.50% | 21.96% | -4.54% | -24.21% | 8.99% | 19.30% | 21.62% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BIOGY is 73, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Biogaia AB ADR (BIOGY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Biogaia AB ADR provided a 7.88% dividend yield over the last twelve months, with an annual payout of $0.71 per share. The company has been increasing its dividends for 4 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.71 | $0.64 | $0.28 | $0.12 | $0.08 | $0.08 | $0.08 | $0.15 | $0.12 | $0.33 |
Dividend yield | 7.88% | 6.43% | 2.79% | 1.41% | 0.72% | 0.62% | 0.00% | 0.00% | 0.00% | 0.00% |
Monthly Dividends
The table displays the monthly dividend distributions for Biogaia AB ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.71 | $0.71 | ||||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.64 | ||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | |
| 2022 | $0.00 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | |||
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | ||
| 2020 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | ||
| 2019 | $0.08 | $0.08 | |||||||||||
| 2018 | $0.15 | $0.15 | |||||||||||
| 2017 | $0.12 | $0.12 | |||||||||||
| 2016 | $0.25 | $0.09 | $0.33 |
Dividend Yield & Payout
Dividend Yield
Biogaia AB ADR has a dividend yield of 7.88%, which means its dividend payment is significantly above the market average.
Payout Ratio
Biogaia AB ADR has a payout ratio of 2.47%, which is below the market average. This means Biogaia AB ADR returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Biogaia AB ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Biogaia AB ADR was 46.12%, occurring on Oct 14, 2022. The portfolio has not yet recovered.
The current Biogaia AB ADR drawdown is 26.03%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -46.12% | Sep 29, 2020 | 81 | Oct 14, 2022 | — | — | — |
| -38.9% | Mar 2, 2020 | 6 | Mar 18, 2020 | 8 | Jun 24, 2020 | 14 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Biogaia AB ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Biogaia AB ADR, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Biogaia AB ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for BIOGY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BIOGY has a P/E ratio of 29.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for BIOGY compared to other companies in the Drug Manufacturers - Specialty & Generic industry. BIOGY currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BIOGY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BIOGY has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BIOGY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BIOGY has a P/B value of 5.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |